Population pharmacokinetics and pharmacodynamics of warfarin in healthy young adults
暂无分享,去创建一个
Malcolm Rowland | Leon Aarons | L. Aarons | M. Rowland | Maria Pitsiu | Eva M. Parker | M. Pitsiu | E. Parker
[1] R. P. Zolton. Synthetic peptide substrate assays for hemostasis testing. , 1986, Advances in clinical chemistry.
[2] R. Bell,et al. Inhibition by warfarin enantiomers of prothrombin synthesis, protein carboxylation, and the regeneration of vitamin K from vitamin K epoxide. , 1981, Biochemical pharmacology.
[3] N. Holford. Clinical Pharmacokinetics and Pharmacodynamics of Warfarin , 1986, Clinical pharmacokinetics.
[4] A. Breckenridge,et al. Kinetics of warfarin absorption in man , 1973, Clinical pharmacology and therapeutics.
[5] D. Mungall,et al. Effect of using warfarin plasma concentrations in Bayesian forecasting of prothrombin-time response. , 1987, Clinical pharmacy.
[6] A Racine-Poon,et al. A Bayesian approach to nonlinear random effects models. , 1985, Biometrics.
[7] R. O'Reilly. Stereoselective Interaction of Sulfinpyrazone with Racemic Warfarin and Its Separated Enantiomorphs in Man , 1982, Circulation.
[8] D. Rubin,et al. Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper , 1977 .
[9] L. Aarons,et al. Enoxacin‐warfarin interaction: Pharmacokinetic and stereochemical aspects , 1987, Clinical pharmacology and therapeutics.
[10] L B Sheiner,et al. Estimating population kinetics. , 1982, Critical reviews in biomedical engineering.
[11] L B Sheiner,et al. Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods. , 1982, Journal of pharmaceutical sciences.
[12] M. Rowland,et al. Stereospecific fluorescence high-performance liquid chromatographic analysis of warfarin and its metabolites in plasma and urine. , 1984, Journal of pharmaceutical sciences.
[13] B. Osterud,et al. Coupled amidolytic assay for factor VII: its use with a clotting assay to determine the activity state of factor VII. , 1978, Blood.